[The efficacy and outlook for the study of live vaccines for the prevention of melioidosis]
- PMID: 10356737
[The efficacy and outlook for the study of live vaccines for the prevention of melioidosis]
Abstract
The effect of immunization with Burkholderia pseudomallei, (Pur- and Ts), heterologous vaccines and the recombinant culture of Francisella tularensis RM2, carrying a plasmid with fragments of B. pseudomallei chromosome, was studied on four species of experimental animals, essentially differing by their sensitivity to melioidosis. B. pseudomallei mutants formed the statistically significant level of protection in subcutaneously challenged animals, moderately sensitive to melioidosis, but were not effective when tested, under the same conditions, in animals, highly sensitive to melioidosis. The effect produced by the experimental vaccines under study in animals of all species, subjected to aerogenic challenge, was leveled. The study showed good prospects for the use of tularemia vaccine with a view to create heterologous immunity to melioidosis and the possibility of its use as the basis of bivalent gene engineering vaccine.
Similar articles
-
[The outlook for the development of live vaccines for the prevention of melioidosis].Zh Mikrobiol Epidemiol Immunobiol. 1999 May-Jun;(3):52-5. Zh Mikrobiol Epidemiol Immunobiol. 1999. PMID: 10851991 Russian.
-
[Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease].Zh Mikrobiol Epidemiol Immunobiol. 2004 Mar-Apr;(2):38-42. Zh Mikrobiol Epidemiol Immunobiol. 2004. PMID: 15188557 Russian.
-
Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.Infect Immun. 2013 Dec;81(12):4626-34. doi: 10.1128/IAI.00915-13. Epub 2013 Oct 7. Infect Immun. 2013. PMID: 24101688 Free PMC article.
-
Development of Burkholderia mallei and pseudomallei vaccines.Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 23508691 Free PMC article. Review.
-
Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Vaccine. 2017. PMID: 28336210 Review.
Cited by
-
Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule.Clin Vaccine Immunol. 2013 Jul;20(7):1041-7. doi: 10.1128/CVI.00113-13. Epub 2013 May 15. Clin Vaccine Immunol. 2013. PMID: 23677322 Free PMC article.